Your Health, We Care

Home >Drug List>Lenvatinib>Indications of Lenvatinib

Lenvatinib(LuciLenva)

Release date: 2026-01-05 15:45:46     Recommended: 99

Lenvatinib is indicated for differentiated thyroid carcinoma (DTC), renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and endometrial carcinoma (EC).